Clinical Liver Disease (CLD) is a digital educational resource published on behalf of the American Association for the Study of Liver Diseases (AASLD). Each issue delivers between eight and fifteen short articles (approximately 800-1000 words, 10 references, and 4-5 graphics), as well as relevant links to other AASLD online educational material. CLD articles are accompanied by podcasts, video interviews, and/or slide sets that help emphasize the key teaching points for a clinical audience, and readers can earn Continuing Medical Education (CME) credits for reading, watching, and listening to the content.
Under the direction of Editor-in-Chief Michael Lucey, MD, the CLD Editorial Board is responsible for planning issues, reviewing submissions, contributing to the audio/visual elements, and writing board-style questions. For a list of the Deputy and Associate Editors making up the Editorial Board, please click here.
The aim of CLD is to provide education for clinicians diagnosing and managing patients with liver disease. Peer review for each submission, conducted by the Editorial Board, attempts to maintain this focus.
Article Preparation and Submission
Each submission should be 800-1000 words and contain 10 references and 4-5 graphics. Your complete submission can be emailed to CLD@aasld.org or uploaded directly to CLD's online manuscript submission system, ScholarOne Manuscrips, at http://mc.manuscriptcentral.com/cld
Title: No more than 120 characters, not including spaces between words.
Author Names: The full name, email, and institutional affiliation of all authors must be included.
Abstract: No abstract is requested.
References: Number references in the order cited as Arabic numerals in parentheses on the line. Only literature that is published or in press (with the name of the publication known) may be numbered and listed; abstracts and letters to the editor may be cited.
Use Index Medicus as the style guide for references and other journal abbreviations.
List all authors up to six, using six and "et al." when the number is greater than seven.
EndNote is a software product that we recommend to authors to help simplify and streamline the process.
Figures: All figures must be in TIFF or EPS format, and have a resolution of at least 300 DPI at full size with no compression.
Figures should be numbered with Arabic numerals in the order mentioned in the text. Provide a title and sufficient explanation. Explain all abbreviations and symbols. Provide figure legends at the end of the main text. Indicate that permission has been obtained for copyrighted material.
Copyright: Copyright of all material published in CLD is vested in the American Association for the Study of Liver Diseases. A Copyright Agreement form signed by all authors must accompany all manuscripts.
After acceptance of your written article, the Editorial Board will determine the audio/visual format that will best illustrate the educational message. At that time, AASLD staff will attempt to schedule an interview to be taped, podcast to be recorded, etc, that is convenient for you and maintains our production schedule.
Although issues are planned in advance by the Editorial Board, unsolicited submissions will be evaluated based on their educational value and synchronicity to CLD's upcoming topics to be addressed.
Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
Conflict of Interest
Clinical Liver Disease requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise, which might be perceived as influencing an author's objectivity, is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. All conflict of interest (or information specifying the absence of conflict of interest) should be included at submission. The existence of a conflict of interest does not preclude publication in this journal.
READ FROM THE AASLD:
A Message from the AASLD President
United States Travel Restrictions
Download the App
New Android App Available!
iOS App for iPad or iPhone